---
figid: PMC2762943__nihms137299f2
figlink: /pmc/articles/PMC2762943/figure/F2/
number: F2
caption: 'The retinoblastoma gene product (Rb) pathway. Rb is the main downstream
  effector of p53 in the control of G1 arrest. This Rb function depends on the level
  of phosphorylation of Rb, which is achieved by cyclin-dependent kinases (CDK) 2
  and 4 in complex with either cyclin E or cyclin D1. These kinases complexes are
  retro-controlled by the following CDK inhibitors: p21 (the transcriptional target
  of p53), p16 (INK4β) and p27 (kip1). Phosphorylated Rb releases E2F1 from binding
  to Rb, which allows E2F1 transcriptional activities on S-phases genes target and
  disrupt the G1 checkpoint. Loss of functional CDK inhibitors p53, activation/gain
  of cyclin D1 or cyclin E, and Rb loss all result in E2F1 activation and disruption
  of the G1 checkpoint.'
pmcid: PMC2762943
papertitle: 'Pathogenesis of lung cancer signaling pathways: roadmap for therapies.'
reftext: E. Brambilla, et al. Eur Respir J. ;33(6):1485-1497.
pmc_ranked_result_index: '70744'
pathway_score: 0.9559873
filename: nihms137299f2.jpg
figtitle: The retinoblastoma gene product (Rb) pathway
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2762943__nihms137299f2.html
  '@type': Dataset
  description: 'The retinoblastoma gene product (Rb) pathway. Rb is the main downstream
    effector of p53 in the control of G1 arrest. This Rb function depends on the level
    of phosphorylation of Rb, which is achieved by cyclin-dependent kinases (CDK)
    2 and 4 in complex with either cyclin E or cyclin D1. These kinases complexes
    are retro-controlled by the following CDK inhibitors: p21 (the transcriptional
    target of p53), p16 (INK4β) and p27 (kip1). Phosphorylated Rb releases E2F1 from
    binding to Rb, which allows E2F1 transcriptional activities on S-phases genes
    target and disrupt the G1 checkpoint. Loss of functional CDK inhibitors p53, activation/gain
    of cyclin D1 or cyclin E, and Rb loss all result in E2F1 activation and disruption
    of the G1 checkpoint.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - E2F1
  - TP53
  - E2F4
  - E2F3
  - E2F7
  - E2F8
  - E2F5
  - E2F2
  - E2F6
genes:
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
chemicals: []
diseases: []
figid_alias: PMC2762943__F2
redirect_from: /figures/PMC2762943__F2
figtype: Figure
---
